Across TCGA pan-cancer cohorts, TUBAP7 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of TUBAP7’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where TUBAP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TUBAP7 is over-expressed in tumor.
HNSC and COAD are the cancer types where TUBAP7 tumor–normal differential expression is most reproducible.